Skip to main content
RGEN logo

RGEN

Repligen Corporation

$163.88

3.76%

Trade Ideas Performance

Latest Closed Trade Idea

$163.88

3.76%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

11

Social

34

About

Events of Repligen Corporation (RGEN)

Over the past six months (May-November 2026), Repligen reported record Q3 2026 revenue of $209.3 million, a 10.9% year-over-year increase, with adjusted EPS of $0.53 beating expectations, though a GAAP net loss of $38.4 million was due to an impairment charge. Management raised its full-year 2026 guidance. The company completed the acquisition of BioLife Solutions in October 2026, expected to contribute $24 million in Q4 2026 revenue and be accretive to 2027 earnings. While chromatography, proteins, and analytics franchises grew significantly, filtration declined by 11%. As of November 5, 2026, the share price was $168.47, a 16.20% increase from a year prior, with its 52-week range between $100.99 and $198.87. The stock showed a bullish cross in October but moved below its 50-day moving average in November, suggesting a potential downward trend.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)